Federico Aldegheri

5PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)BiomechanicsRheumatology and arthritisVeterinary virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 02, 2026
Response to: Letter to the editor regarding: Real‑world rebound pattern of serum collagen type I C‑telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment‑induced bone loss.

|Mar 06, 2026
Real-world rebound pattern of serum collagen type I C-telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment-induced bone loss.

Federico Aldegheri, Angelo Fassio, Matteo Appoloni

|Feb 09, 2026
Fracture risk tools performance and potential use in systemic lupus erythematosus.

Federico Aldegheri, Denise Rotta, Isotta Galvagni

|Jan 10, 2026
Longitudinal Comparison of Calprotectin and C-Reactive Protein in Rheumatoid Arthritis: Real-World Evidence Across Three Targeted Therapies.

Angelo Fassio, Isotta Galvagni, Silvia Sartoris

|Sep 09, 2024
The role of 18FDG-PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature.

Riccardo Bixio, Sara Bindoli, Andrea Morciano

Pageof 1